Hi,
+1 from me.
Kind regards
Karl Heinz Marbaise
On 20.04.22 20:32, Michael Osipov wrote:
Hi,
We solved 5 issues:
https://issues.apache.org/jira/secure/ReleaseNote.jspa?projectId=12317922&version=12351596
There are still a couple of issues left in JIRA:
https://issues.apache.org/jira/issues/
+1
Reproducible Build ok: reference done with JDK 8 on Windows
Regards,
Hervé
Le samedi 23 avril 2022, 12:28:59 CEST Michael Osipov a écrit :
> Am 2022-04-20 um 20:32 schrieb Michael Osipov:
> > Hi,
> >
> > We solved 5 issues:
> > https://issues.apache.org/jira/secure/ReleaseNote.jspa?projectI
+1
- build from source-release ok
to investigation
- team report contains only one person [1]
[1]
https://maven.apache.org/shared-archives/maven-reporting-impl-LATEST/team.html
śr., 20 kwi 2022 o 20:32 Michael Osipov napisał(a):
> Hi,
>
> We solved 5 issues:
>
> https://issues.apache.org/jira
Am 2022-04-20 um 20:32 schrieb Michael Osipov:
Hi,
We solved 5 issues:
https://issues.apache.org/jira/secure/ReleaseNote.jspa?projectId=12317922&version=12351596
There are still a couple of issues left in JIRA:
https://issues.apache.org/jira/issues/?jql=project%20%3D%20MSHARED%20AND%20resolu
Am 2022-04-20 um 20:32 schrieb Michael Osipov:
Hi,
We solved 5 issues:
https://issues.apache.org/jira/secure/ReleaseNote.jspa?projectId=12317922&version=12351596
There are still a couple of issues left in JIRA:
https://issues.apache.org/jira/issues/?jql=project%20%3D%20MSHARED%20AND%20resolu
+1
śr., 20 kwi 2022, 20:32 użytkownik Michael Osipov
napisał:
> Hi,
>
> We solved 5 issues:
>
> https://issues.apache.org/jira/secure/ReleaseNote.jspa?projectId=12317922&version=12351596
>
> There are still a couple of issues left in JIRA:
>
> https://issues.apache.org/jira/issues/?jql=project%2
Hi,
We solved 5 issues:
https://issues.apache.org/jira/secure/ReleaseNote.jspa?projectId=12317922&version=12351596
There are still a couple of issues left in JIRA:
https://issues.apache.org/jira/issues/?jql=project%20%3D%20MSHARED%20AND%20resolution%20%3D%20Unresolved%20AND%20component%20%3D%20m